share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4：持股变动声明-董事 Burrell Terry-Ann
美股sec公告 ·  07/03 16:41
Moomoo AI 已提取核心信息
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on July 1, 2024. The transaction involved a grant of 1,843 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 71,254 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on July 1, 2024. The transaction involved a grant of 1,843 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 71,254 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell，Recursion药品公司[RXRX]的相关人员，于2024年7月1日完成了股票收购。该交易涉及免费授予1,843股A类普通股。交易后，Burrell在公司中的直接持股数量增至总共71,254股。该授予是公司股票激励计划的一部分，反映了将员工利益与股东利益保持一致的持续承诺。
Terry-Ann Burrell，Recursion药品公司[RXRX]的相关人员，于2024年7月1日完成了股票收购。该交易涉及免费授予1,843股A类普通股。交易后，Burrell在公司中的直接持股数量增至总共71,254股。该授予是公司股票激励计划的一部分，反映了将员工利益与股东利益保持一致的持续承诺。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息